Auxergen Biolongevity Laboratory — Form D
Auxergen Biolongevity Laboratory of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-24. The offering totals $5.0M, of which $25K was reported sold. Industry: Other.
Offering
- Filed: 2023-05-24
- Form: D
- Accession: 0001969864-23-000007
- Industry: Other
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $25K
- Remaining: $5.0M
- Minimum investment: $5K
- Investors: 2
- Date of first sale: 2023-04-24
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-482483
Issuer
- Name: Auxergen Biolongevity Laboratory
- CIK: 0001969864
- Entity type: Limited Liability Company
- Jurisdiction: MARYLAND
- Incorporated: 2022
- Address: 701 EAST PRATT STREET SUITE 4011, BALTIMORE, MD, 21202
- Phone: 410-336-9877
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Gregory Paul Contreras | Director | Baltimore, MD |
| Ting Yu Yeh | Director | Baltimore, MD |
| Gregory Paul Contreras | Executive Officer | Baltimore, MD |
| Ting Yu Yeh | Executive Officer | Baltimore, MD |
More